|
华润医药集团有限公司, 03320.HK - 综合损益表 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
2015-12 |
2014-12 |
2013-12 |
营业额 |
204,453,869 |
189,689,107 |
172,532,204 |
156,705,203 |
146,568,105 |
135,749,180 |
116,950,696 |
经营溢利 |
6,499,151 |
9,105,596 |
8,441,553 |
7,994,501 |
7,992,071 |
6,858,133 |
6,857,996 |
非经营/ 特殊项目 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
联营公司 |
140,417 |
76,881 |
140,795 |
48,164 |
58,224 |
64,640 |
54,917 |
除税前经营溢利 |
6,639,568 |
9,182,477 |
8,582,348 |
8,042,665 |
8,050,295 |
6,922,773 |
6,912,913 |
税项 |
1,541,765 |
1,610,153 |
1,715,482 |
2,074,576 |
1,968,061 |
1,430,902 |
1,458,286 |
少数股东权益 |
1,811,384 |
3,594,721 |
3,383,830 |
3,146,679 |
3,232,158 |
2,845,931 |
2,815,110 |
股东应占溢利 |
3,286,419 |
3,977,603 |
3,483,036 |
2,821,410 |
2,850,076 |
2,645,940 |
2,639,517 |
货币 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
单位 |
主要项目 |
折旧 |
2,364,847 |
1,517,403 |
1,489,405 |
1,211,811 |
1,288,615 |
1,276,601 |
1,133,737 |
利息 |
3,717,188 |
2,939,091 |
2,267,000 |
1,830,984 |
2,091,864 |
2,164,437 |
1,805,012 |
利息拨作发展资本 |
4,787 |
4,814 |
36,051 |
34,922 |
41,402 |
29,838 |
34,278 |
处置/重估固定资产 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
税率(%) |
23.22 |
17.54 |
19.99 |
25.79 |
24.45 |
20.67 |
21.1 |
营业额增长(%) |
7.78 |
9.94 |
10.1 |
6.92 |
7.97 |
16.07 |
0.0 |
股东应占溢利增长(%) |
-17.38 |
14.2 |
23.45 |
-1.01 |
7.72 |
0.24 |
0.0 |
核数师意见 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
说明:1代表无保留意见;2代表保留意见;3代表修改意见
|
|